Abris CEE Mid-Market III LP fund, managed by Europe-based investment company Abris Capital Partners, has signed a contract to acquire 100% of the shares in Poland-based healthcare network operator, Scanmed SA, from Life Healthcare Group Holdings Limited, it was reported on Thursday.
The deal is subject to regulatory approvals and is likely to be completed in the first quarter of 2021.
Abris aims to support Scanmed in the expansion of its service offering and geographic coverage and in the continued improvement of its medical facilities and care in key therapeutic areas. The firm also aims to increase commercial revenues in orthopaedics, ophthalmology, rehabilitation and urogynecology, and to open new labs and surgery units.
Eli Lilly increases quarterly dividend
Pfizer's board approves higher dividend for Q1 2021
Medifast announces quarterly cash dividend
Medivir and TetraLogic renegotiate birinapant agreement
China Accepts Emapalumab Marketing Authorization Application for Review
Abris to acquire 100% of Scanmed shares
Quest Diagnostics announces quarterly cash dividend
Pfizer negotiating with Brazil to supply its COVID-19 vaccine by early 2021
MEI Pharma reports financial results for Q3 ended 30 September 2020